According to a Wall Street Journal story published on Monday, the US health authorities has given billionaire Elon Musk’s Neuralink the green light to implant its brain chip in a second person after the company offered to address an issue that came up with its first patient.
Neuralink said earlier this month that its first patient’s small wire implants had come loose. According to sources cited by Reuters last week, the business was aware that the wires may retract based on animal research.
According to a document the WSJ saw and a source familiar with the firm, the company plans to address the issue by implanting part of the device’s cables deeper into the brain.
More than 1,000 quadriplegics have registered for Neuralink’s patient registry, and the company aims to implant its device in a second patient in June and ten individuals overall this year, according to the article.
According to the report, the business also plans to apply for similar trials to start in the coming months to authorities in Britain and Canada. As per the FDA, it is not permitted to talk about or provide details about any specific company’s application for or research involving human trials.
An inquiry for comment from Reuters was not immediately answered by Neuralink.
According to the business, the first patient to have the brain chip implanted was able to use their thoughts to manipulate a computer mouse in February with “no ill effects.”
Neuralink states that a brain-computer interface implant is surgically inserted into a brain area that governs the intention to move using a robot in this investigation.
